Risk factor
High price volatility
Profitability factor
Favourable analyst view
About
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant...
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers.
Target Price
The average target price of SIBN is 24 and suggests 57% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell